Alliqua BioMedical

Alliqua BioMedical (NASDAQ: ALQA) develops and manufactures electron-beam cross-linked sheet gels for the original equipment manufacturer market.

[Alliqua BioMedical @alliquainc]

Adynxx Completes Merger with Alliqua BioMedical, Adds Pierre Legault and Matt Ruth to Board of Directors https://t.co/VFnL6xBWxE

[Alliqua BioMedical @alliquainc]

Alliqua BioMedical CEO Provides Update to Shareholders https://t.co/b1jW3d4elm

[Alliqua BioMedical @alliquainc]

Alliqua BioMedical Declares Contingent Special Dividend of $1.05 per Share and Announces Record Date for the... https://t.co/ZvIgUjKVrl

[Alliqua BioMedical @alliquainc]

Alliqua Biomedical CEO Provides Update to Shareholders https://t.co/UVIElDM0jS

[Alliqua BioMedical @alliquainc]

Alliqua ($ALQA) to spin off and merge its Contract Manufacturing Business with TO Pharmaceuticals LLC to Create an Independent, Publicly Traded Company focused on Cannabinoid-Based Pharmaceutical Therapies: https://t.co/mXIwC7bxEb

[Alliqua BioMedical @alliquainc]

Alliqua BioMedical ($ALQA) and Adynxx, Inc. Announce Merger Agreement to Create NASDAQ-listed Clinical-Stage Pharmaceutical Company with a Focus on Pain and Inflammation: https://t.co/qZnksDKYxy

[Alliqua BioMedical @alliquainc]

Alliqua BioMedical Inc. and Adynxx, Inc. Announce Merger Agreement to Create NASDAQ-listed Clinical-Stage... https://t.co/1xKqaTSA4B

[Alliqua BioMedical @alliquainc]

Alliqua BioMedical, Inc. Announces Closing Asset Sale to Celularity Inc. https://t.co/zRXU7dMA4P

[Alliqua BioMedical @alliquainc]

Alliqua BioMedical, Inc. Announces Definitive Asset Purchase Agreement with Celularity, Inc. https://t.co/VdSp1PgRWM

[Alliqua BioMedical @alliquainc]

Alliqua BioMedical, Inc. Reports Third Quarter of Fiscal Year 2017 Financial Results and Increases Fiscal Year... https://t.co/xxbHIj4shz

[Alliqua BioMedical @alliquainc]

Alliqua BioMedical, Inc. Engages Cowen to Assist in Evaluating Potential Strategic Alternatives https://t.co/TNhLKIObwQ

[Alliqua BioMedical @alliquainc]

Alliqua BioMedical, Inc. to Announce Third Quarter of Fiscal Year 2017 Results on November 9th https://t.co/Yz80FJSe9i

[Alliqua BioMedical @alliquainc]

Alliqua BioMedical, Inc. Announces 1-for-10 Reverse Stock Split https://t.co/JnQbtRqP37

[Alliqua BioMedical @alliquainc]

Alliqua BioMedical, Inc. Announces the Sale of TheraBond® 3D Antimicrobial Barrier Systems Product Line; Alliqua... https://t.co/YmX8SO0sQ9

[Alliqua BioMedical @alliquainc]

Alliqua BioMedical, Inc. Reports Second Quarter of Fiscal Year 2017 Financial Results https://t.co/7dnUuc4Z23

[Alliqua BioMedical @alliquainc]

Alliqua BioMedical, Inc. to Announce Second Quarter of Fiscal Year 2017 Results on August 10th https://t.co/avDomZVrB5

[Alliqua BioMedical @alliquainc]

Alliqua BioMedical, Inc. Announces Partnership with Partners Capital Group to Provide UltraMIST® Customers with... https://t.co/B53lCHb4MT

[Alliqua BioMedical @alliquainc]

Alliqua BioMedical, Inc. Reports First Quarter of Fiscal Year 2017 Financial Results https://t.co/XQy9RAVivj

[Alliqua BioMedical @alliquainc]

Alliqua BioMedical, Inc. Receives Extension from Nasdaq to Regain Compliance with Minimum Bid Price Requirement https://t.co/JpTnLW9O9R

[Alliqua BioMedical @alliquainc]

Alliqua BioMedical, Inc. Announces Preliminary First Quarter Fiscal 2017 Revenue and Updates Fiscal Year 2017... https://t.co/wcJ0wpUbx3